Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02467166 · ClinicalTrials.gov registry record · NA
Evaluation of the CIRCA Monitoring System in Prevention of Esophageal Lesions Following RFCA
A NA study, sponsored by University of California, San Diego.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT02467166 is a NA study that has completed, run by University of California, San Diego. The registered enrollment target is 40 participants.
The verdict
NCT02467166, a NA study, has completed, sponsored by University of California, San Diego.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if the use of Circa™ temperature monitoring system during ablation procedures will reduce the risk of esophageal lesions or damage. Esophageal lesions caused by ablation could later develop into a potentially fatal atrio-esophageal fistula, which is hole between the upper chamber of the heart and the esophagus. Although development of atrio-esophageal fistula following atrial fibrillation ablation is extremely rare, the complication is severe and potentially life-threatening. Therefore, monitoring of esophageal temperatures has been adopted to prevent the development of esophageal lesions. The Circa™ temperature monitoring system allows cardiac electrophysiologists to monitor and thereby limit temperatures as well as duration of ablation in the esophagus throughout the procedure.
Interventions
- DEVICE Circa™ Probe
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2015-06 |
| Est. Completion | 2020-05-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02467166
The ClinicalTrials.gov registry entry for NCT02467166 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Diego, which has 775 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Circa™ Probe is the first listed.
NCT02467166 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02467166 about?
NCT02467166 is a clinical study titled "Evaluation of the CIRCA Monitoring System in Prevention of Esophageal Lesions Following RFCA". The purpose of this study is to determine if the use of Circa™ temperature monitoring system during ablation procedures will reduce the risk of esophageal lesions or damage. Esophageal lesions caused by ablation could later develop into a potentially fatal atrio-esophageal fistula, which is hole bet...
What is the current status of trial NCT02467166?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2015-06. Estimated completion is 2020-05-05.
What interventions are being tested in trial NCT02467166?
The interventions under investigation include: Circa™ Probe (DEVICE).
Who is sponsoring clinical trial NCT02467166?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.